Annual Accounts Payable
$3.70 M
+$1.75 M+89.61%
December 31, 2023
Summary
- As of February 8, 2025, OVID annual accounts payable is $3.70 million, with the most recent change of +$1.75 million (+89.61%) on December 31, 2023.
- During the last 3 years, OVID annual accounts payable has fallen by -$1.74 million (-32.01%).
- OVID annual accounts payable is now -48.04% below its all-time high of $7.13 million, reached on December 31, 2021.
Performance
OVID Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.71 M
-$2.01 M-42.58%
September 30, 2024
Summary
- As of February 8, 2025, OVID quarterly accounts payable is $2.71 million, with the most recent change of -$2.01 million (-42.58%) on September 30, 2024.
- Over the past year, OVID quarterly accounts payable has dropped by -$992.90 thousand (-26.81%).
- OVID quarterly accounts payable is now -61.98% below its all-time high of $7.13 million, reached on December 31, 2021.
Performance
OVID Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
OVID Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +89.6% | -26.8% |
| 3 y3 years | -32.0% | -26.8% |
| 5 y5 years | -1.4% | -26.8% |
OVID Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -48.0% | +89.6% | -62.0% | +162.3% |
| 5 y | 5-year | -48.0% | +89.6% | -62.0% | +198.0% |
| alltime | all time | -48.0% | +452.3% | -62.0% | +216.2% |
Ovid Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.71 M(-42.6%) |
| Jun 2024 | - | $4.72 M(+31.3%) |
| Mar 2024 | - | $3.60 M(-2.9%) |
| Dec 2023 | $3.70 M(+89.6%) | $3.70 M(+204.4%) |
| Sep 2023 | - | $1.22 M(-67.7%) |
| Jun 2023 | - | $3.76 M(+105.5%) |
| Mar 2023 | - | $1.83 M(-6.2%) |
| Dec 2022 | $1.95 M(-72.6%) | $1.95 M(+89.0%) |
| Sep 2022 | - | $1.03 M(-77.6%) |
| Jun 2022 | - | $4.62 M(+104.6%) |
| Mar 2022 | - | $2.26 M(-68.3%) |
| Dec 2021 | $7.13 M(+30.9%) | $7.13 M(+126.9%) |
| Sep 2021 | - | $3.14 M(+245.4%) |
| Jun 2021 | - | $909.50 K(-71.1%) |
| Mar 2021 | - | $3.15 M(-42.2%) |
| Dec 2020 | $5.45 M | $5.45 M(+72.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $3.16 M(-31.8%) |
| Jun 2020 | - | $4.63 M(+16.1%) |
| Mar 2020 | - | $3.99 M(+22.6%) |
| Dec 2019 | $3.26 M(-13.3%) | $3.26 M(-39.0%) |
| Sep 2019 | - | $5.34 M(+160.8%) |
| Jun 2019 | - | $2.05 M(-53.6%) |
| Mar 2019 | - | $4.41 M(+17.4%) |
| Dec 2018 | $3.76 M(+85.4%) | $3.76 M(-18.2%) |
| Sep 2018 | - | $4.59 M(+33.9%) |
| Jun 2018 | - | $3.43 M(+43.1%) |
| Mar 2018 | - | $2.40 M(+18.3%) |
| Dec 2017 | $2.03 M(+136.3%) | $2.03 M(+39.1%) |
| Sep 2017 | - | $1.46 M(-59.2%) |
| Jun 2017 | - | $3.57 M(+126.1%) |
| Mar 2017 | - | $1.58 M(+84.3%) |
| Dec 2016 | $857.20 K(+27.8%) | $857.20 K |
| Dec 2015 | $670.50 K | - |
FAQ
- What is Ovid Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Ovid Therapeutics?
- What is Ovid Therapeutics annual accounts payable year-on-year change?
- What is Ovid Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Ovid Therapeutics?
- What is Ovid Therapeutics quarterly accounts payable year-on-year change?
What is Ovid Therapeutics annual accounts payable?
The current annual accounts payable of OVID is $3.70 M
What is the all time high annual accounts payable for Ovid Therapeutics?
Ovid Therapeutics all-time high annual accounts payable is $7.13 M
What is Ovid Therapeutics annual accounts payable year-on-year change?
Over the past year, OVID annual accounts payable has changed by +$1.75 M (+89.61%)
What is Ovid Therapeutics quarterly accounts payable?
The current quarterly accounts payable of OVID is $2.71 M
What is the all time high quarterly accounts payable for Ovid Therapeutics?
Ovid Therapeutics all-time high quarterly accounts payable is $7.13 M
What is Ovid Therapeutics quarterly accounts payable year-on-year change?
Over the past year, OVID quarterly accounts payable has changed by -$992.90 K (-26.81%)